Posts

Why Hanmi’s Deals With Genentech and Eli Lilly Matter Beyond Korea’s Drug Industry

As Yuhan Corp. Nears 100 Years, South Korea’s Oldest Pharmaceutical Story Turns Toward a Global Future

A New Korean Combination Drug Highlights a Global Shift in Treating High Blood Pressure and Cholesterol Together

At AACR 2026, Korean biotech shows cancer drug race is shifting from one-shot bets to platform strategy